Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
fantastic people, great benefits, remote environment, patient focused, noble mission, bring your dog to work, growth and opportunities
Cosa ti piace di più del team di leadership?
transparent, care about employees, smart and passionate, inspiring
Che cosa ti rende più felice sul posto di lavoro?
the people, the entrepreneurial work,
Qual è la parte migliore del tuo compenso?
generous bonus and opportunity to earn more stock based on performance
Quali sono alcune delle cose migliori della tuo team?
collaborative, mission focused, willing to do what it takes, smart and fun
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
focus on DEI, community week events bring teams and people together, transparent communications, celebrating successes and people, focus on people first
Other Employee Reviews for Karyopharm Therapeutics
×